Sloan-K. Cancer Center

We have finished the collaboration with the Memorial Sloan-Kettering Cancer Center of New York by financing a research on Retinoblastoma managed by Dr. David Abramson and his team. This is the most common malignant cancer of the eye in children. For more than 100 years the only treatment was the removal of the eye; but in this new research, Dr Abramson has demonstrated that this technique is no longer necessary and that 95% of the eyes treated can be saved.

Share on social networks:

Other projects that may interest you

Collaboration with HSJD 2017

In 2017, Invest for children has made a donation to Children’s Hospital Sant Joan de Déu of Barcelona, with the aim to continue with the research of children’s diseases. Most…
see project